MatthewGilruthDavisMD

Research • Rochester, NY

Medical Director at Rochester Clinical Research, Inc.

Join to view full profile

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Davis' full profile

Already have an account?

Office
500 Helendale Rd
Suite L20
Rochester, NY 14609
Phone+1 585-288-0890

Fax+1 585-288-0893

Education & Training

UPMC Medical Education/Presbyterian Shadyside HospitalResidency, Family Medicine, 1986 - 1989
University of Rochester School of Medicine and DentistryClass of 1986

Certifications & Licensure

NY State Medical License 1992 - 2027
PA State Medical License 1987 - 1994
National Board of Physicians and Surgeons Family Medicine

Clinical Trials

Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Start of enrollment: 2011 Sep 01
Completed
Phase 3
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
Completed
Phase 2
A Study of LY2623091 in Participants With High Blood Pressure Start of enrollment: 2014 Aug 01
Completed
Phase 2
Randomized Trial in Adult Participants With Acute Migraines Start of enrollment: 2020 Oct 27
Completed
Phase 3
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years Start of enrollment: 2022 May 12
COMPLETED
PHASE3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

23 citations
Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older
Robert W. Frenck, Anne Fiquet, Alejandra Gurtman, Martin van Cleeff, Matthew Davis
Vaccine. 2016-06-24